New option for HIV prevention.
YEZTUGO or lenacapavir was initially approved in 2022 by the FDA as a component of an HIV treatment regimen. In (June 18, 2025) it earned approval as a preventive treatment with 99.9% effectiveness shown in the trials.
Call us today. Come in to see if Yeztugo is good for you.
913-362-0220